Class II recall: Teva Pharmaceuticals USA, Inc: traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured
Teva Pharmaceuticals USA has issued a Class II recall of traZODone Hydrochloride Tablets, USP, 50 mg (100-tablet bottles, NDC 50111-560-01), manufactured in Croatia by Pliva Hrvatska for Teva. The recall was initiated due to the presence of foreign tablets or capsules within the affected product.
Most relevant for: Patients prescribed this specific lot of Teva trazodone 50 mg tablets and the pharmacies or clinicians managing their care.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More family medicine updates
- Long-Acting Injectable HIV Therapy Noninferior for Adherence ChallengesOct 15, 2026
- 8-week sofosbuvir-velpatasvir regimen non-inferior to 12 weeks for HCVSep 30, 2026
- Lean MASLD shows milder histology but similar mortality outcomesSep 30, 2026
- Oral GLP-1 orforglipron shows cardiovascular non-inferiority to insulin glargineSep 30, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026